Given that DNA damage is able to activate multiple cellular signal pathways, such as the PI3K/AKT pathway and the MAPK/ERK pathway [32, 45], we reason that DNA damage accumulation in NSCLC cells is one of the triggers for the ERK pathway activation following XPC silencing. The gene discussed is MAPK1; the disease is non-small cell lung carcinoma.